GMRE — Global Medical REIT Income Statement
0.000.00%
Last trade - 00:00- $545.03m
- $1.18bn
- $141.05m
- 54
- 62
- 45
- 53
Annual income statement for Global Medical REIT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 70.7 | 93.7 | 116 | 137 | 141 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 61.1 | 96.2 | 98.7 | 124 | 135 |
| Operating Profit | 9.59 | -2.5 | 17.3 | 13.2 | 6.17 |
| Gain / Loss on Sale of Assets | |||||
| Net Income Before Taxes | 9.59 | -2.5 | 18.3 | 20 | 21.7 |
| Net Income After Taxes | 9.59 | -2.5 | 18.3 | 20 | 21.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 9.23 | -1.93 | 17.6 | 19.1 | 20.6 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.41 | -7.75 | 11.8 | 13.3 | 14.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.109 | -0.16 | 0.179 | 0.106 | 0.002 |
| Dividends per Share |